| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Bortezomib | CTRPv2 | pan-cancer | AAC | 0.083 | 0.02 |
| mRNA | XL-184 | GDSC1000 | pan-cancer | AAC | 0.082 | 0.02 |
| mRNA | JQ-1:vorinostat (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.077 | 0.02 |
| mRNA | BMS-345541 | GDSC1000 | pan-cancer | AAC | 0.074 | 0.02 |
| mRNA | CX-5461 | GDSC1000 | pan-cancer | AAC | 0.074 | 0.02 |
| mRNA | GDC-0449 | GDSC1000 | pan-cancer | AAC | 0.083 | 0.02 |
| mRNA | BRD-K79669418 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.02 |
| mRNA | linifanib | GDSC1000 | pan-cancer | AAC | 0.08 | 0.02 |
| mRNA | Roscovitine | GDSC1000 | pan-cancer | AAC | 0.13 | 0.02 |
| mRNA | TPCA-1 | GDSC1000 | pan-cancer | AAC | 0.063 | 0.03 |